Golden Valley Development, Inc (GVDI)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2015 | 11 Million USD | 567.72% |
| 2014 | 1.64 Million USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2022 FY | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2016 Q1 | 1.9 Million USD | -82.68% |
| 2015 Q2 | 1.26 Million USD | -24.7% |
| 2015 Q3 | 11.24 Million USD | 790.22% |
| 2015 Q4 | 11 Million USD | -2.13% |
| 2015 FY | 11 Million USD | 567.72% |
| 2015 Q1 | 1.67 Million USD | 1.79% |
| 2014 Q4 | 1.64 Million USD | 0.0% |
| 2014 FY | 1.64 Million USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Medical Technologies Inc. | 133.82 Thousand USD | 100.0% |
| Ansell Limited | 457.04 Million USD | 100.0% |
| Ansell Limited | 457.9 Million USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 43.33 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | 27.89 Thousand USD | 100.0% |
| Psykey, Inc. | 49.94 Thousand USD | 100.0% |
| ConvaTec Group Plc | 395.54 Million USD | 100.0% |
| ConvaTec Group Plc | 396.1 Million USD | 100.0% |
| Encision Inc. | 1.4 Million USD | 100.0% |
| Hear AtLast Holdings, Inc. | - USD | NaN% |
| Innovative MedTech Inc. | -9294.00 USD | 100.0% |
| LifePoint, Inc. | 2.3 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | 441 Thousand USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | 91.88 Thousand USD | 100.0% |
| Reflect Scientific, Inc. | 972.29 Thousand USD | 100.0% |
| SmileDirectClub, Inc. | 49.87 Million USD | 100.0% |
| Sector 10, Inc. | - USD | NaN% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | 100.0% |
| SheerVision, Inc. | 339.66 Thousand USD | 100.0% |
| United Health Products, Inc. | 33.59 Thousand USD | 100.0% |
| Vasamed, Inc. | 449.02 Thousand USD | 100.0% |
| Wearable Health Solutions, Inc. | 8555.00 USD | 100.0% |
| Yubo International Biotech Limited | 322.17 Thousand USD | 100.0% |